Åsa Kristina Öjlert (Åsa Kristina Õjlert)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Venues

Molecular oncology

Acta oncologica (Stockholm, Sweden)

Oslo Universitetssykehus Institutt for kreftforskning

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oslo Universitetssykehus Institutt for kreftforskning Aug 14 2017

Norway

PhD student :: Department of Cancer Genetics

Publications

Henrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard, Lotte Victoria Rogg, Nina Helbekkmo, Bjørn Henning Grønberg, Tarje Onsøien Halvorsen, Christina Ramberg, Vilde Drageset Haakensen, Åsa Kristina Öjlert, Maria Moksnes Bjaanaes, Åslaug Helland
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial. Molecular oncology (2022)
Åsa Kristina Öjlert, Daniel Nebdal, Igor Snapkov, Vibeke Olsen, Joel Kidman, Victor Greiff, Jonathan Chee, Åslaug Helland
Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor. Molecular oncology 15 (11) (2021)
Åsa Kristina Öjlert, Daniel Nebdal, Marius Lund-Iversen, Renée Åstrøm Ellefsen, Odd Terje Brustugun, Jon Michael Gran, Ann Rita Halvorsen, Åslaug Helland
Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy. Acta oncologica (Stockholm, Sweden) 60 (2) (2020)
Åsa Kristina Öjlert, Ann Rita Halvorsen, Daniel Nebdal, Marius Lund-Iversen, Steinar Solberg, Odd Terje Brustugun, Ole Christian Lingjaerde, Åslaug Helland
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery. Molecular oncology 13 (5) (2019)
Ann Rita Halvorsen, Miriam Ragle Aure, Åsa Kristina Öjlert, Odd Terje Brustugun, Steinar Solberg, Daniel Nebdal, Åslaug Helland
Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC. Molecular oncology 13 (12) (2019)

Åsa Kristina Öjlert.css-eqlu8i{font-size:small;padding-left:4px;} (Åsa Kristina Õjlert)

Publication Activity (10 Years)

Top Topics

Top Venues

Åsa Kristina Öjlert (Åsa Kristina Õjlert)